-

Mirion Announces Earnings Release and Conference Call Date for Second Quarter 2025

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that it will release financial results for second quarter 2025 after market close on Thursday, July 31, 2025. Following the news release, the company will host a conference call the next day, Friday, August 1, 2025, at 10:00 am ET to discuss the results.

Participants may access the call by dialing 1-877-407-9208 or 1-201-493-6784, and requesting to join the Mirion Technologies, Inc. earnings call. A live webcast will also be available at https://ir.mirion.com/news-events.

A telephonic replay will be available shortly after the conclusion of the call and until August 15, 2025. Participants may access the replay at 1-844-512-2921 or 1-412-317-6671 with access code 13754545. An archived replay of the call will also be available on the Investors portion of the Mirion website at https://ir.mirion.com/.

About Mirion

Mirion (NYSE: MIR) is a global leader in radiation safety, science and medicine, empowering innovations that deliver vital protection while harnessing the transformative potential of ionizing radiation across a diversity of end markets. The Mirion Nuclear & Safety group provides proven radiation safety technologies that operate with precision – for essential work within R&D labs, critical nuclear facilities, and on the front lines. The Mirion Medical group solutions help enhance the delivery and ensure safety in healthcare, powering the fields of Nuclear Medicine, Radiation Therapy QA, Occupational Dosimetry, and Diagnostic Imaging. Headquartered in Atlanta (GA – USA), Mirion employs approximately 2,800 people and operates in 12 countries. Learn more at mirion.com.

Contacts

For investor inquiries, please contact:

Eric Linn
ir@mirion.com

Industry:

Mirion

NYSE:MIR
Release Versions
English

Contacts

For investor inquiries, please contact:

Eric Linn
ir@mirion.com

More News From Mirion

Mirion Crew Active Dosimeters to Be Worn by Astronauts on NASA's Artemis II Mission

ATLANTA--(BUSINESS WIRE)--As NASA prepares for the Artemis II launch, Mirion, a leading provider of advanced radiation safety solutions, today announced that its Crew Active Dosimeters (CAD) will be carried in astronauts’ pockets aboard the Artemis II mission, providing personal, time-resolved radiation monitoring during the program’s first crewed flight. Artemis II will carry astronauts on an approximately 10-day mission around the Moon, marking a major milestone in NASA’s Artemis program to r...

Mirion to Present at Citi’s 2026 Global Industrial Tech and Mobility Conference

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR) announced today that Chairman and Chief Executive Officer, Thomas Logan, and Chief Financial Officer and Medical Group President, Brian Schopfer, will present at Citi’s 2026 Global Industrial Tech and Mobility Conference. The presentation will begin at 2:40 PM ET on Wednesday, February 18, 2026. The presentation will be webcast live at Mirion's Investor Relations Page where a webcast link will be displayed under the "Events and Presentations” section...

Mirion Announces Executive Appointments to Accelerate Strategic Growth and Market Focus

ATLANTA--(BUSINESS WIRE)--Mirion (NYSE: MIR), a global leader in radiation detection, measurement, analysis and monitoring solutions for the nuclear, medical, defense and research end markets, today announced three new leadership appointments supporting the company’s continued focus on safety, innovation, operational excellence and long-term growth. Chief Nuclear Officer: Tighe Smith Mirion has promoted Tighe Smith to the newly created role of Chief Nuclear Officer. Reporting to Thomas Logan, M...
Back to Newsroom